Switch View
© Globe Newswire
10.09.2025
ISIN: US92243A2006
Vaxart Inc
VXRT
LISTED
NASDAQ
Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate
News Preview
- Second-generation constructs induce robust increases in fecal IgA, which was shown to be correlated with protection against infection in the company’s previous Phase 2b challenge study -...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: IL0011809592
NeuroSense Therapeutics Ltd.
NRSN
LISTED
NASDAQ
NeuroSense's Drug Candidate Shows Early Signals of Benefit in Alzheimer's Patient-Derived Neurons
News Preview
Initial Phase 2 RoAD trial results demonstrate improvements in brain-cell connectivity and health, with a favorable safety profile
CAMBRIDGE, Mass., Sept. 10, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative disease...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US22663K1079
Crinetics Pharmaceuticals Inc
CRNX
LISTED
NASDAQ
Crinetics Pharmaceuticals Announces September 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on September 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 62,475 shares of its common stock and granted an aggregate of 43,800 restricted stock un...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
10.09.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Rosen Law Firm Encourages Encompass Health Corporation Investors to Inquire About Securities Class Action Investigation - EHC
News Preview
NEW YORK, Sept. 10, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE: EHC) result...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
10.09.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
News Preview
NEW YORK, Sept. 10, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR).
If you cu...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US05337M1045
Avadel Pharmaceuticals plc
AVDL
LISTED
NASDAQ
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
News Preview
DUBLIN, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non-statutory options to five (5) new employees to purchase 165,520 ordinary shares under Avadel’...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US28531P1030
electroCore, Inc.
ECOR
LISTED
NASDAQ
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
News Preview
ROCKAWAY, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Andy Brown has joined electroCore, effective September 9, 2025, as the Company’s VP, Corporate Controller. The Compensation Committee of electroCore’s Board of D...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
News Preview
NEW YORK, Sept. 10, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting f...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US76155X1000
Revolution Medicines Inc
RVMD
LISTED
NASDAQ
Revolution Medicines Shares New Clinical Results Supporting Initiation of RASolute 303, a Global Phase 3 Registrational Trial of Daraxonrasib in First Line Metastatic Pancreatic Ductal Adenocarcinoma
News Preview
Long-term follow-up data for daraxonrasib monotherapy in second line metastatic pancreatic ductal adenocarcinoma reinforces promising clinical activity and durability...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US25056L1035
Design Therapeutics Inc
DSGN
LISTED
NASDAQ
Design Therapeutics Appoints Justin Gover to Board of Directors
News Preview
CARLSBAD, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the appointment of industry veteran Justin Gover to its Board of Directors, effective immediately....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US10806X1028
BridgeBio Pharma, Inc.
BBIO
LISTED
NASDAQ
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
PALO ALTO, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that the compensation committee of its board of directors (the “committee”) approved equity grants in the form of restricted stock units (“...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Savara Inc. (“Savara” or “the Company”) (NASDAQ: SVRA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors w...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
10.09.2025
ISIN: CA46604F1099
Izotropic Corporation
IZO
LISTED
CSE
Izotropic Gains Visibility as AI Market Broadens Beyond Tech
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - September 10, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Transaction in Own Shares
News Preview
For immediate release10 September 2025 WORLDWIDE HEALTHCARE TRUST PLC(the "Company") MARKET PURCHASE OF COMPANY'S OWN SHARES This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 9 July 2025 to make market purchases of the Company's own shares up to an aggregate maximum of 69,602,221...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Sept. 10, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST).
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN RXSIGHT, INC. (RXST), CONTACT THE L...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Sept. 10, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Blocklisting - Interim Review
News Preview
BLOCK LISTING SIX MONTHLY RETURN INFORMATION PROVIDED ON THIS FORM MUST BE TYPED OR PRINTED ELECTRONICALLY AND PROVIDED TO A PIP. (Note: Italicised terms have the same meaning as given in the UK Listing Rules.)Date: 10 September 2025 Name of applicant: Worldwide Healthcare Trust PLC Name of scheme: General...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.09.2025
ISIN: US15870P3073
Champions Oncology Inc
CSBR
LISTED
NASDAQ
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
News Preview
HACKENSACK, NJ / ACCESS Newswire / September 10, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the quarter ended July 31, 2025, on Monday, September 15, 2025, after market close. The company...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Gilead Sciences Commits to Veeva Vault CRM
News Preview
Next generation CRM with deep capabilities and agentic AI
PLEASANTON, Calif., Sept. 10, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Gilead Sciences has committed to Veeva Vault CRM.
"Gilead is a leader in l...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Gilead Sciences Commits to Veeva Vault CRM
News Preview
Next generation CRM with deep capabilities and agentic AI
PLEASANTON, Calif., Sept. 10, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Gilead Sciences has committed to Veeva Vault CRM.
"Gilead is a leader in life changing medicines and has been a pioneer of major scientific advancements in virology, inflammation, and oncolo...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.09.2025
ISIN: BE0003755692
AGFA Gevaert NV
AGFB
LISTED
EURONEXT
AGFA HealthCare Strengthens Market Position in KLAS Enterprise Imaging Report 2025
News Preview
CARLSTADT, NJ / ACCESS Newswire / September 10, 2025 / AGFA HealthCare has been recognized by KLAS Research for significant satisfaction gains. Customer satisfaction with AGFA's Enterprise Imaging VNA and XERO® Viewer has increased significantly over the past 18 months, with both solutions named Best in KLAS 2025 winners.KLAS Report - Enterpri...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA – TRANSPARENCY NOTIFICATION
News Preview
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US88165K1016
Tevogen Bio Holdings Inc.
TVGN
LISTED
NASDAQ
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston
News Preview
WARREN, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that Mittul Mehta, Chief Information Officer of Tevogen and Head of Tevogen.AI, will participate as a panelist in the Startup Forum at the Databricks DATA + AI World Tour on October 8, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US09073N2018
BioSig Technologies, Inc.
BSGM
LISTED
NASDAQ
BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.
News Preview
Strategic Rebranding to Focus on Expanded Business Model and Growth Strategy. New Ticker Symbol “STEX”. Strategic Rebranding to Focus on Expanded Business Model and Growth Strategy. New Ticker Symbol “STEX”....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: CH0012100191
Tecan Group AG
TECN
LISTED
SIX
Tecan announces change of leadership in the Partnering Business division
News Preview
Männedorf, Switzerland, September 10, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today announced a change of leadership in its Partnering Business division.Ralf Griebel, who has served as Head of the Partnering Business division and as a member of the Management Board since April 2020, will be leaving the Company to pursue other opportunitie...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
Idorsia shares new analyses of daridorexant for patients with insomnia at World Sleep 2025
News Preview
Allschwil, Switzerland – September 10, 2025Idorsia Ltd (SIX: IDIA) shares new analyses of daridorexant for patients with insomnia and further characterizes insomnia disorder at World Sleep 2025, delivering on its ongoing commitment to further the science of sleep and insomnia....
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: CA00288U1066
Abcellera Biologics Inc
ABCL
LISTED
NASDAQ
AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer
News Preview
AbCellera (Nasdaq: ABCL) today announced the appointment of Sarah Noonberg, M.D., Ph.D., as Chief Medical Officer. Dr. Noonberg, a board-certified physician-scientist, brings over two decades of industry experience leading development programs from discovery through to global regulatory approvals and commercialization across a diverse range of ind...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
CVS Health Foundation awards $1 Million in Hometown Fund grants to boost local impact across Rhode Island
News Preview
Grants will support local nonprofits improving health outcomes across the state
WOONSOCKET, R.I., Sept. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) Foundation announced today that it is awarding $1 million in general operating grants through its Hometown Fund to 20 Rhode Island-based organizations. These organizations are committed to making...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
CVS Health Foundation awards $1 Million in Hometown Fund grants to boost local impact in Hartford
News Preview
Grants will support local nonprofits improving health outcomes across the Greater Hartford area
HARTFORD, Conn., Sept. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) Foundation announced today that it is awarding $1 million in general operating grants through its Hometown Fund to 20 organizations surrounding the Hartford area. These organizatio...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments
News Preview
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new category in men’s health, offering access to innovative, affordable, and personalized treatment plans for low testosterone.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/h...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US55279B3015
Lite Strategy, Inc.
LITS
LISTED
NASDAQ
MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS’
News Preview
MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI” or the “Company”) today announced that it will change its corporate name to Lite Strategy, Inc., reflecting the Company’s expansion into a pioneer in digital asset treasury management. Alongside the rebrand, the Company’s ticker symbol on the NASDAQ Stock Market will transition from MEIP to LITS, effective at...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research
News Preview
Beckman Coulter Also Announces Development of Aß-42 Research Use Only Immunoassay Test
BREA, Calif., Sept. 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and a leader in global clinical diagnostics innovation, today launched the industry's first fully automated Brain-derived Tau (BD-Tau) research use only (RUO) immunoassa...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
Dexcom Launches Its First Open Call to Uncover the Next Diabetes Advocates Ahead of World Diabetes Day
News Preview
DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of its first open call in the U.S. and Canada in search of the next diabetes advocates. Those selected will experience a once-in-a-lifetime opportunity to raise awareness and share their voice on a global scale this World Diabetes Day (Nov. 14) and bey...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Healthcare and the HCA Healthcare Foundation Strengthen Collaboration with the American Heart Association to Advance Cardiovascular and Stroke Care, Clinical Research and Education
News Preview
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, and the HCA Healthcare Foundation today announced they will continue their collaboration with the American Heart Association on their Getting to the Heart of Stroke™ initiative through $3.9 million in funding and support. This builds upon the collaboration announced...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US44148G2049
Hoth Therapeutics, Inc.
HOTH
LISTED
NASDAQ
Hoth Therapeutics Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities
News Preview
NEW YORK, Sept. 10, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced it has submitted its Clinical Trial Application (CTA) to the European Medicines Agency (EMA) to expand its ongoing Phase II trial of HT-001, a novel topical therapeutic for skin toxicities associated with...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04NET ASSET VALUEThe estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 9 September 2025 was 365.99p (cum income). ...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US1404752032
Sonida Senior Living Inc
SNDA
LISTED
NYSE
Sonida Closes Previously Announced Senior Living Asset Acquisition in Dallas-Fort Worth
News Preview
Sonida Senior Living, Inc. (“Sonida” or the “Company”) (NYSE: SNDA), a leading owner, operator and investor in senior living communities, announced today the closing of its latest acquisition. The Company continues to execute on its inorganic growth strategy, which aims to further expand, densify and upgrade its portfolio to fully leverage operati...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: KYG9845F2080
LakeShore Biopharma Co Ltd
LSBCF
LISTED
OTC
LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
News Preview
BEIJING, Sept. 10, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB, "LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the indep...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US54948X1090
Lucid Diagnostics Inc.
LUCD
LISTED
NASDAQ
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
News Preview
NEW YORK, Sept. 10, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the pricing of its underwritten public offering of 25,000,000 shares of its common stock at a public offering pr...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: BE0003739530
UCB SA
UCB
LISTED
EURONEXT
Gen Z and Millennial Patients with Chronic Rheumatic Diseases Are Opening Up to Raise Awareness for Improved Care
News Preview
Survey insights reveal that despite many participants living with psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA), which includes both non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS), feeling misunderstood, a significant majority remain open to dialogue—74% of the 34 Gen Z and 67% of the 216 Millen...
Themefolio
Profiler
Peergroup
© Newsfile
10.09.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments
News Preview
Highlights include Expanded Global Patent Portfolio, Complete Debt Elimination Strengthening Balance Sheet, and Further Momentum of Pivotal Clinical TrialWhite Bear Lake, Minnesota--(Newsfile Corp. - September 10, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully impl...
Themefolio
Profiler
Peergroup
© Newsfile
10.09.2025
ISIN: US4222172086
Hear AtLast Holdings, Inc.
HRAL
LISTED
OTC
Hear At Last and GGA & Associates Successfully Conclude First Order for Portable Homes for Jamaica Project
News Preview
Kingston, Jamaica--(Newsfile Corp. - September 10, 2025) - Hear At Last (OTCID: HRAL), a leading provider of innovative solutions, in partnership with GGA & Associates, is proud to announce the successful completion of their first order involving the transfer of funds for portable homes under the Jamaica Project. This milestone marks the begin...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US2183521028
Corcept Therapeutics Inc
CORT
LISTED
NASDAQ
FDA Files Corcept’s New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
News Preview
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the U.S. Food and Drug Administration (FDA) has accepted Corcept’s...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US46266C1053
IQVIA Holdings Inc
IQV
LISTED
NYSE
IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced the launch of its Clinical Trial Financial Suite (CTFS), an AI-enabled platform orchestrating all financial aspects of clinical trials. CTFS is designed to elimin...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions
News Preview
GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire icometrix, a company focused on providing AI-powered brain imaging analysis for neurological disorders such as Alzheimer’s disease to meet the growing demand for MRI in personalized treatment planning.
To complement its MR-guided AI-assisted scanning experti...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US45828J1034
Intensity Therapeutics, Inc.
INTS
LISTED
NASDAQ
Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update
News Preview
A pathological complete response ("pCR") has been observed in the first patient evaluated in Cohort A, where each patient receives two doses of INT230-6 eight days apart, followed by the standard of care immunochemotherapy ("SOC")Safety looks favorable in Cohort ASome INT230-6 patients begin to show localized skin irritation, and new patient enro...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte to Present New Data Highlighting Progress Across its Dermatology Pipeline at the European Association of Dermatology and Venerology 2025 Congress
News Preview
Today Incyte (Nasdaq:INCY) announced that it will present new data from its dermatology portfolio at the European Association of Dermatology and Venerology (EADV) 2025 Congress, held from September 17 – 20, in Paris. Highlights include late-breaking, oral and poster presentations featuring data for povorcitinib (INCB054707), an oral small-molecule...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US04280A1007
Arrowhead Pharmaceuticals Inc
ARWR
LISTED
NASDAQ
Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies
News Preview
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has filed a request for regulatory clearance to initiate a Phase 1/2a clinical trial of ARO-MAPT, the company’s investigational RNA interference (RNAi) therapeutic being developed as a potential treatment for tauopathies including Alzheimer’s disease, a progressive neurodegener...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US67092M2089
Nutriband Inc.
NTRB
LISTED
NASDAQ
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
News Preview
Q2 results...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Invitation: Sobi's NASP and Uncontrolled Gout call and webcast
News Preview
NASP (previously known as SEL-212) - clinical program overview and uncontrolled gout disease landscape.
STOCKHOLM, Sept. 10, 2025 /PRNewswire/ -- Investors, analysts, and members of the media are invited to a conference call on Tuesday, 16 September, at 16:30 CEST, 15:30 BST, and 10:30 EDT. The call will present insights from management and Dr. H...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US89422G1076
Travere Therapeutics Inc
TVTX
LISTED
NASDAQ
Travere Therapeutics Provides Update on FDA Advisory Committee Meeting for FILSPARI® (sparsentan) in FSGS
News Preview
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that following further review of the supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) in focal segmental glomerulosclerosis (FSGS), an advisory committee is no longer needed. The sNDA remains under...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US05370A1088
Avidity Biosciences Inc
RNA
LISTED
NASDAQ
Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD44
News Preview
-- Unprecedented improvement compared to baseline and natural history in multiple functional measures including Time to Rise from Floor (TTR), 4-Stair Climb (4SC), Performance of Upper Limb (PUL) and 10-Meter Walk/Run Test (10mWRT) at approximately one year --
-- Unprecedented rapid reduction in creatine kinase (CK) to near normal levels maintain...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US48576U2050
Karyopharm Therapeutics Inc
KPTI
LISTED
NASDAQ
Karyopharm Announces Completion of Enrollment in the Phase 3 SENTRY Trial in Myelofibrosis
News Preview
– Top-Line Results Anticipated in March 2026 –
NEWTON, Mass., Sept. 10, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it has completed enrollment in the Phase 3 SENTRY trial, which is evaluating selinexor in combination with ruxol...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US64051A1016
NeOnc Technologies Holdings Inc
NTHI
LISTED
NASDAQ
NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
News Preview
CALABASAS, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today announced that the U.S. Food and Drug Administration (FDA) has authorized the Company to pr...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences’ nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced that the company will present clinical data on benign thyroid nodule ablation using nPulse™ Vybrance™ technology at the American Thyroid Association Ann...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US69608A1088
Palantir Technologies, Inc.
PLTR
LISTED
NASDAQ
Palantir and Hadean Partner to Bring a Suite of Simulation and AI Products Across the UK Armed Forces
News Preview
Palantir Technologies Inc. (NASDAQ: PLTR), a leading provider of AI systems, and Hadean, one of the UK’s leading defence tech scale ups, have today announced a partnership which will see Hadean’s leading edge wargaming, command & control and battlefield training products deployed on Palantir’s Foundry software.
Hadean is at the forefront of...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US0050831009
Actuate Therapeutics, Inc.
ACTU
LISTED
NASDAQ
Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
News Preview
CHICAGO and FORT WORTH, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), today...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US31573L1052
FibroBiologics Inc.
FBLG
LISTED
NASDAQ
FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies
News Preview
Pilot studies have shown encouraging results that are supporting the company’s pre-IND enabling development, marking a critical step toward clinical translation of the Bone Marrow Organoid technology Pilot studies have shown encouraging results that are supporting the company’s pre-IND enabling development, marking a critical step toward clinical t...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US1140822099
Eterna Therapeutics Inc.
ERNA
LISTED
NASDAQ
Ernexa Therapeutics Provides Update on Operational Excellence and Performance
News Preview
The company’s operating loss declined by 51% year-over-year, reflecting a laser focus on relentless execution and significant progress in expense reduction The company’s operating loss declined by 51% year-over-year, reflecting a laser focus on relentless execution and significant progress in expense reduction...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US04301G1022
Artelo Biosciences, Inc.
ARTL
LISTED
NASDAQ
Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms
News Preview
SOLANA BEACH, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced the publication of new preclinical data on ART...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
